Cargando…

Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis

Embelin, as an inhibitor of the X-linked inhibitor of apoptosis protein (XIAP), may induce apoptosis in various types of cancer cells. The present study aimed to determine the effect of Embelin on the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of osteosarcoma c...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Hao, Chen, Yao, Huang, Tao, Liu, Tiemin, Li, Xiucheng, Jiang, Guangjian, Zhang, Wei, Cheng, Shuo, Li, Pengcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921233/
https://www.ncbi.nlm.nih.gov/pubmed/29731867
http://dx.doi.org/10.3892/ol.2018.8209
_version_ 1783317965494550528
author Qian, Hao
Chen, Yao
Huang, Tao
Liu, Tiemin
Li, Xiucheng
Jiang, Guangjian
Zhang, Wei
Cheng, Shuo
Li, Pengcheng
author_facet Qian, Hao
Chen, Yao
Huang, Tao
Liu, Tiemin
Li, Xiucheng
Jiang, Guangjian
Zhang, Wei
Cheng, Shuo
Li, Pengcheng
author_sort Qian, Hao
collection PubMed
description Embelin, as an inhibitor of the X-linked inhibitor of apoptosis protein (XIAP), may induce apoptosis in various types of cancer cells. The present study aimed to determine the effect of Embelin on the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of osteosarcoma cells. Embelin and TRAIL were applied to U2OS and MG63 cells, respectively or in combination. MTT was initially used to detect the difference in survival rates between the group receiving combined application of 100 ng/ml TRAIL and 20 µmol/l Embelin and the individual application groups. Light microscopic quantification was used to detect the morphology of the osteosarcoma cells in each group. Determination of cell apoptosis was subsequently performed using flow cytometry. The invasive ability of the cells was detected by a Transwell assay, prior to relative protein expression being determined by western blot analysis. Based on all the test data, it was revealed that the survival rates and the invasive ability were significantly lower following the combined application of 100 ng/ml TRAIL and 20 µmol/l Embelin than following the individual application of either (P<0.01). Additionally, upregulating expression of caspases, as well as death receptor 5, and downregulating expression of XIAP and matrix metalloproteinase 9 (MMP-9), had more significant effects in the combined group compared with the individual group and the control group. All these results suggested that Embelin may enhance TRAIL-induced apoptosis and inhibit the invasion of human osteosarcoma cells.
format Online
Article
Text
id pubmed-5921233
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-59212332018-05-04 Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis Qian, Hao Chen, Yao Huang, Tao Liu, Tiemin Li, Xiucheng Jiang, Guangjian Zhang, Wei Cheng, Shuo Li, Pengcheng Oncol Lett Articles Embelin, as an inhibitor of the X-linked inhibitor of apoptosis protein (XIAP), may induce apoptosis in various types of cancer cells. The present study aimed to determine the effect of Embelin on the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of osteosarcoma cells. Embelin and TRAIL were applied to U2OS and MG63 cells, respectively or in combination. MTT was initially used to detect the difference in survival rates between the group receiving combined application of 100 ng/ml TRAIL and 20 µmol/l Embelin and the individual application groups. Light microscopic quantification was used to detect the morphology of the osteosarcoma cells in each group. Determination of cell apoptosis was subsequently performed using flow cytometry. The invasive ability of the cells was detected by a Transwell assay, prior to relative protein expression being determined by western blot analysis. Based on all the test data, it was revealed that the survival rates and the invasive ability were significantly lower following the combined application of 100 ng/ml TRAIL and 20 µmol/l Embelin than following the individual application of either (P<0.01). Additionally, upregulating expression of caspases, as well as death receptor 5, and downregulating expression of XIAP and matrix metalloproteinase 9 (MMP-9), had more significant effects in the combined group compared with the individual group and the control group. All these results suggested that Embelin may enhance TRAIL-induced apoptosis and inhibit the invasion of human osteosarcoma cells. D.A. Spandidos 2018-05 2018-03-08 /pmc/articles/PMC5921233/ /pubmed/29731867 http://dx.doi.org/10.3892/ol.2018.8209 Text en Copyright: © Qian et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Qian, Hao
Chen, Yao
Huang, Tao
Liu, Tiemin
Li, Xiucheng
Jiang, Guangjian
Zhang, Wei
Cheng, Shuo
Li, Pengcheng
Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis
title Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis
title_full Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis
title_fullStr Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis
title_full_unstemmed Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis
title_short Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis
title_sort combined application of embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921233/
https://www.ncbi.nlm.nih.gov/pubmed/29731867
http://dx.doi.org/10.3892/ol.2018.8209
work_keys_str_mv AT qianhao combinedapplicationofembelinandtumornecrosisfactorrelatedapoptosisinducingligandinhibitsproliferationandinvasioninosteosarcomacellsviacaspaseinducedapoptosis
AT chenyao combinedapplicationofembelinandtumornecrosisfactorrelatedapoptosisinducingligandinhibitsproliferationandinvasioninosteosarcomacellsviacaspaseinducedapoptosis
AT huangtao combinedapplicationofembelinandtumornecrosisfactorrelatedapoptosisinducingligandinhibitsproliferationandinvasioninosteosarcomacellsviacaspaseinducedapoptosis
AT liutiemin combinedapplicationofembelinandtumornecrosisfactorrelatedapoptosisinducingligandinhibitsproliferationandinvasioninosteosarcomacellsviacaspaseinducedapoptosis
AT lixiucheng combinedapplicationofembelinandtumornecrosisfactorrelatedapoptosisinducingligandinhibitsproliferationandinvasioninosteosarcomacellsviacaspaseinducedapoptosis
AT jiangguangjian combinedapplicationofembelinandtumornecrosisfactorrelatedapoptosisinducingligandinhibitsproliferationandinvasioninosteosarcomacellsviacaspaseinducedapoptosis
AT zhangwei combinedapplicationofembelinandtumornecrosisfactorrelatedapoptosisinducingligandinhibitsproliferationandinvasioninosteosarcomacellsviacaspaseinducedapoptosis
AT chengshuo combinedapplicationofembelinandtumornecrosisfactorrelatedapoptosisinducingligandinhibitsproliferationandinvasioninosteosarcomacellsviacaspaseinducedapoptosis
AT lipengcheng combinedapplicationofembelinandtumornecrosisfactorrelatedapoptosisinducingligandinhibitsproliferationandinvasioninosteosarcomacellsviacaspaseinducedapoptosis